Related Experiment Video
Updated: Aug 9, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1
N Pathan1, C Aime-Sempe, S Kitada
1The Burnham Institute, 10901 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
Abstract:
Bcl-2 is a critical suppressor of apoptosis that is overproduced in many types of cancer. Phosphorylation of the Bcl-2 protein is induced on serine residues in tumor cells arrested by microtubule-targeting drugs (paclitaxel, vincristine, nocodazole) and has been associated with inactivation of antiapoptotic function through an unknown mechanism. Comparison of a variety of pharmacological inhibitors of serine/threonine-specific protein kinases demonstrated that the cyclin-dependent kinase inhibitor, flavopiridol, selectively blocks Bcl-2 phosphorylation induced by antimicrotubule drugs. Bcl-2 could also be coimmunoprecipitated with the kinase Cdc2 in M-phase-arrested cells, suggesting that Cdc2 may be responsible for phosphorylation of Bcl-2 in cells treated with microtubule-targeting drugs. Examination of several serine-->alanine substitution mutants of Bcl-2 suggested that serine 70 and serine 87 represent major sites of Bcl-2 phosphorylation induced in response to microtubule-targeting drugs. Both these serines are within sequence contexts suitable for proline-directed kinases such as Cdc2. Phosphorylated Bcl-2 protein was discovered to associate in M-phase-arrested cells with Pin1, a mitotic peptidyl prolyl isomerase (PPIase) known to interact with substrates of Cdc2 during mitosis. In contrast, phosphorylation of Bcl-2 induced by microtubule-targeting drugs did not alter its ability to associate with Bcl-2 (homodimerization), Bax, BAG1, or other Bcl-2-binding proteins. Since the region in Bcl-2 containing serine 70 and serine 87 represents a proline-rich loop that has been associated with autorepression of its antiapoptotic activity, the discovery of Pin1 interactions with phosphorylated Bcl-2 raises the possibility that Pin1 alters the conformation of Bcl-2 and thereby modulates its function in cells arrested with antimicrotubule drugs.
Insights
Bcl-2 phosphorylation by Cdc2 kinase, triggered by microtubule-targeting drugs, may inactivate its anti-apoptotic function. This phosphorylation leads to Pin1 interaction, potentially altering Bcl-2
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- Bcl-2 is a key apoptosis suppressor overexpressed in cancers.
- Microtubule-targeting drugs induce Bcl-2 phosphorylation, reducing its anti-apoptotic role via unknown mechanisms.
- Understanding Bcl-2 regulation is crucial for cancer therapy development.
Purpose of the Study:
- To elucidate the mechanism of Bcl-2 inactivation by microtubule-targeting drugs.
- To identify the kinase responsible for Bcl-2 phosphorylation and the specific phosphorylation sites.
- To investigate the functional consequences of Bcl-2 phosphorylation, including protein interactions.
Main Methods:
- Pharmacological inhibition of serine/threonine-specific protein kinases.
- Co-immunoprecipitation assays to identify interacting proteins.
- Site-directed mutagenesis (serine to alanine substitutions) to map phosphorylation sites.
- Analysis of protein-protein interactions using co-immunoprecipitation.
Main Results:
- Flavopiridol, a cyclin-dependent kinase inhibitor, selectively blocked Bcl-2 phosphorylation induced by antimicrotubule drugs.
- Cdc2 kinase was identified as a potential phosphorylating agent for Bcl-2 in M-phase-arrested cells.
- Serines 70 and 87 were identified as major phosphorylation sites on Bcl-2.
- Phosphorylated Bcl-2 associated with Pin1, a peptidyl prolyl isomerase, but not with other known binding partners like Bax or BAG1.
- Phosphorylation did not affect Bcl-2 homodimerization or binding to Bax, BAG1.
Conclusions:
- Cdc2-mediated phosphorylation of Bcl-2 at serines 70 and 87 by microtubule-targeting drugs may lead to its functional inactivation.
- The interaction of phosphorylated Bcl-2 with Pin1 suggests a role for Pin1 in modulating Bcl-2's anti-apoptotic activity.
- This mechanism provides a novel target for cancer therapies aimed at reactivating apoptosis in tumor cells.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
08:13Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
Published on: November 30, 2021
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Destabilization of Microtubules
Drugs that Stabilize Microtubules
Microtubule Instability
The Intrinsic Apoptotic Pathway
Drugs that Destabilize Microtubules